MarketPeel
Insider Trading Intelligence
CL

Chase C. Leavitt

LCTX
GENERAL COUNSEL/SECRETARY · LINEAGE CELL THERAPEUTICS, INC. · CIK 0001777467
FILING MIX · LIFETIME100%/0%
BUYS
2
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Mar 2020
HOLDINGS NOW
699,100
AVG SELL PX
TRADE KIND
SHOWING 2 / 2
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Chase C. Leavitt. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
LCTX · 699,100 shares · as of Mar 15, 2021
0174,775349,550524,325699,1002021SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
FLOW · 2 buys / 0 sellsCOVERAGE · 5 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
LCTX
LINEAGE CELL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
699,100699,100Mar 15, 2021Mar 17, 2021
LCTX
LINEAGE CELL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
616,700616,700Mar 17, 2020Mar 19, 2020
Other insiders · LCTX
Loading peer insiders…
About this filer
CIK 0001777467
ROLE
General Counsel/Secretary
PRIMARY
LCTX
COMPANIES
1
ACTIVE SINCE
Mar 2020
MARKETPEEL · /INSIDER/0001777467DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback